目的：研究奥曲肽联合前列地尔治疗急性胰腺炎的疗效。方法将我院62例急性胰腺炎患者按治疗方法分为治疗组（奥曲肽联合前列地尔治疗）和对照组（奥曲肽治疗），均31例，对两组患者临床治疗效果展开对比分析。结果治疗组患者治疗总有效率93.55%、腹痛缓解时间为（3.52±0.41）d、肠鸣音恢复时间为（3.92±0.74）d和血淀粉酶复常时间为（4.11±1.13）d，对照组治疗总有效率为70.97%、腹痛缓解时间为（4.95±0.51）d、肠鸣音恢复时间为（5.52±0.47）d和血淀粉酶复常时间为（6.032±1.14）d。对两组患者临床治疗效果展开对比分析，有一定差异性，P＜0.05。结论奥曲肽联合前列地尔治疗急性胰腺炎效果显著。%Objective:To study the therapeutic effect of octreotide combined with alprostadil in the treatment of acute pancreatitis. Methods:62 cases of acute pancreatitis patients according to treatment methods are divided into the treatment group (combination of octreotide and al-prostadil treatment) and control group (octreotide), and 31 cases were launched, a comparative analysis of two groups of patients with clinical curative effect. Results: the patients in the treatment group the total efficiency of treatment 93.55%, abdominal pain relief time was (3.52 +0.41) d, the recovery time of bowel sound as (3.92 +0.74) D and serum amylase period for (4.11 + 1.13) d, the control group the total effec-tive rate was 70.97%, abdominal pain relief time was (4.95 +0.51) d, recovery time of bowel sound as (5.52 + 0.47) D and serum amylase period for (6.032 +1.14) d. Comparative analysis of two groups of patients with clinical curative effect, there is certain difference, P< 0.05. Conclusion:the combination of octreotide and alprostadil treatment effect significantly in acute pancreatitis.
展开▼
